This study is looking into a procedure called Left Gastric Artery Embolization (LGAE) for people with obesity and Nonalcoholic Steatohepatitis (NASH). NASH is a serious liver condition linked to obesity that can lead to liver damage. The LGAE procedure involves blocking a small blood vessel in the stomach using tiny beads called Embospheres Microspheres. This is done by guiding a thin tube (catheter) through an artery in your wrist or groin to the stomach artery, while doctors watch with X-rays. The goal is to see if this procedure can help you lose weight and improve your NASH. Researchers will measure your weight after 12 months to see if the treatment is successful. You may be able to join if you are between 22 and 65 years old, have a BMI over 35 kg/m2, and meet certain health requirements.

Study design

This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 8 participants.

What's involved

You would undergo a procedure where a catheter is inserted into an artery in your wrist or groin and guided to your stomach. You would also need to comply with all study procedures and be available for the duration of the study.

Compensation

Not stated in the trial record.

Follow-up

Your weight will be measured at 12 months after the procedure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.